Search Results

You are looking at 1 - 10 of 23 items for :

  • "lanreotide Autogel" x
  • Refine by access: All content x
Clear All
E Baudin Endocrine Oncology Unit, Imaging Department, Gustave Roussy, Villejuif, France

Search for other papers by E Baudin in
Google Scholar
PubMed
Close
,
J Capdevila Medical Oncology Department, Vall d’Hebron University Hospital, Vall d’Hebron Institute of Oncology (VHIO), IOB Quirón-Teknon, Barcelona, Spain

Search for other papers by J Capdevila in
Google Scholar
PubMed
Close
,
D Hörsch ENETS Center of Excellence, Zentralklinik Bad Berka GmbH, Bad Berka, Germany

Search for other papers by D Hörsch in
Google Scholar
PubMed
Close
,
S Singh Division of Medical Oncology, University of Toronto, Sunnybrook Odette Cancer Center, Sunnybrook HSC, Toronto, Ontario, Canada

Search for other papers by S Singh in
Google Scholar
PubMed
Close
,
M E Caplin Neuroendocrine Tumour Unit, Royal Free Hospital School of Medicine, London, UK

Search for other papers by M E Caplin in
Google Scholar
PubMed
Close
,
E M Wolin Division of Hematology and Oncology, Icahn School of Medicine at Mount Sinai, New York, New York, USA

Search for other papers by E M Wolin in
Google Scholar
PubMed
Close
,
W Buikhuisen Department of Thorax Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands

Search for other papers by W Buikhuisen in
Google Scholar
PubMed
Close
,
M Raderer Division of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, Austria

Search for other papers by M Raderer in
Google Scholar
PubMed
Close
,
E Dansin Thoracic Oncology Unit, Centre Oscar Lambret, Lille, France

Search for other papers by E Dansin in
Google Scholar
PubMed
Close
,
C Grohe Department of Respiratory Diseases, Evangelische Lungenklinik, Berlin, Germany

Search for other papers by C Grohe in
Google Scholar
PubMed
Close
,
D Ferone Neuroendocrine Tumour Unit, Department of Internal Medicine and Medical Specialties, University of Genova, Genova, Italy

Search for other papers by D Ferone in
Google Scholar
PubMed
Close
,
A Houchard Data and Insights Generation and Strategy, Ipsen, Boulogne-Billancourt, France

Search for other papers by A Houchard in
Google Scholar
PubMed
Close
,
X-M Truong-Thanh Medical Affairs, Ipsen, Boulogne-Billancourt, France

Search for other papers by X-M Truong-Thanh in
Google Scholar
PubMed
Close
,
D Reidy-Lagunes Department of Medicine, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical Center, New York, New York, USA

Search for other papers by D Reidy-Lagunes in
Google Scholar
PubMed
Close
, and
the SPINET Study Group
Search for other papers by the SPINET Study Group in
Google Scholar
PubMed
Close
the SPINET Study Group

gastrointestinal NETs: lanreotide autogel/depot (LAN) in patients with slowly progressive well- or moderately differentiated gastroenteropancreatic (GEP) NETs ( Caplin et al. 2014 ), and octreotide long-acting release (OCT) in patients with well

Open access
Martyn E Caplin Royal Free Hospital, Charité University Medicine Berlin, University of Warmia and Mazury, University of Texas MD Anderson Cancer Center, University Hospital, Department of Oncology of the First Faculty of Medicine and General Teaching Hospital, Robert‐Debré Hospital, Markey Cancer Center, Vall d'Hebron University Hospital, Western General Hospital, Università Cattolica del Sacro Cuore, Ipsen, Ipsen, Beaujon Hospital, Paris Diderot University, London, UK

Search for other papers by Martyn E Caplin in
Google Scholar
PubMed
Close
,
Marianne Pavel Royal Free Hospital, Charité University Medicine Berlin, University of Warmia and Mazury, University of Texas MD Anderson Cancer Center, University Hospital, Department of Oncology of the First Faculty of Medicine and General Teaching Hospital, Robert‐Debré Hospital, Markey Cancer Center, Vall d'Hebron University Hospital, Western General Hospital, Università Cattolica del Sacro Cuore, Ipsen, Ipsen, Beaujon Hospital, Paris Diderot University, London, UK

Search for other papers by Marianne Pavel in
Google Scholar
PubMed
Close
,
Jarosław B Ćwikła Royal Free Hospital, Charité University Medicine Berlin, University of Warmia and Mazury, University of Texas MD Anderson Cancer Center, University Hospital, Department of Oncology of the First Faculty of Medicine and General Teaching Hospital, Robert‐Debré Hospital, Markey Cancer Center, Vall d'Hebron University Hospital, Western General Hospital, Università Cattolica del Sacro Cuore, Ipsen, Ipsen, Beaujon Hospital, Paris Diderot University, London, UK

Search for other papers by Jarosław B Ćwikła in
Google Scholar
PubMed
Close
,
Alexandria T Phan Royal Free Hospital, Charité University Medicine Berlin, University of Warmia and Mazury, University of Texas MD Anderson Cancer Center, University Hospital, Department of Oncology of the First Faculty of Medicine and General Teaching Hospital, Robert‐Debré Hospital, Markey Cancer Center, Vall d'Hebron University Hospital, Western General Hospital, Università Cattolica del Sacro Cuore, Ipsen, Ipsen, Beaujon Hospital, Paris Diderot University, London, UK

Search for other papers by Alexandria T Phan in
Google Scholar
PubMed
Close
,
Markus Raderer Royal Free Hospital, Charité University Medicine Berlin, University of Warmia and Mazury, University of Texas MD Anderson Cancer Center, University Hospital, Department of Oncology of the First Faculty of Medicine and General Teaching Hospital, Robert‐Debré Hospital, Markey Cancer Center, Vall d'Hebron University Hospital, Western General Hospital, Università Cattolica del Sacro Cuore, Ipsen, Ipsen, Beaujon Hospital, Paris Diderot University, London, UK

Search for other papers by Markus Raderer in
Google Scholar
PubMed
Close
,
Eva Sedláčková Royal Free Hospital, Charité University Medicine Berlin, University of Warmia and Mazury, University of Texas MD Anderson Cancer Center, University Hospital, Department of Oncology of the First Faculty of Medicine and General Teaching Hospital, Robert‐Debré Hospital, Markey Cancer Center, Vall d'Hebron University Hospital, Western General Hospital, Università Cattolica del Sacro Cuore, Ipsen, Ipsen, Beaujon Hospital, Paris Diderot University, London, UK

Search for other papers by Eva Sedláčková in
Google Scholar
PubMed
Close
,
Guillaume Cadiot Royal Free Hospital, Charité University Medicine Berlin, University of Warmia and Mazury, University of Texas MD Anderson Cancer Center, University Hospital, Department of Oncology of the First Faculty of Medicine and General Teaching Hospital, Robert‐Debré Hospital, Markey Cancer Center, Vall d'Hebron University Hospital, Western General Hospital, Università Cattolica del Sacro Cuore, Ipsen, Ipsen, Beaujon Hospital, Paris Diderot University, London, UK

Search for other papers by Guillaume Cadiot in
Google Scholar
PubMed
Close
,
Edward M Wolin Royal Free Hospital, Charité University Medicine Berlin, University of Warmia and Mazury, University of Texas MD Anderson Cancer Center, University Hospital, Department of Oncology of the First Faculty of Medicine and General Teaching Hospital, Robert‐Debré Hospital, Markey Cancer Center, Vall d'Hebron University Hospital, Western General Hospital, Università Cattolica del Sacro Cuore, Ipsen, Ipsen, Beaujon Hospital, Paris Diderot University, London, UK

Search for other papers by Edward M Wolin in
Google Scholar
PubMed
Close
,
Jaume Capdevila Royal Free Hospital, Charité University Medicine Berlin, University of Warmia and Mazury, University of Texas MD Anderson Cancer Center, University Hospital, Department of Oncology of the First Faculty of Medicine and General Teaching Hospital, Robert‐Debré Hospital, Markey Cancer Center, Vall d'Hebron University Hospital, Western General Hospital, Università Cattolica del Sacro Cuore, Ipsen, Ipsen, Beaujon Hospital, Paris Diderot University, London, UK

Search for other papers by Jaume Capdevila in
Google Scholar
PubMed
Close
,
Lucy Wall Royal Free Hospital, Charité University Medicine Berlin, University of Warmia and Mazury, University of Texas MD Anderson Cancer Center, University Hospital, Department of Oncology of the First Faculty of Medicine and General Teaching Hospital, Robert‐Debré Hospital, Markey Cancer Center, Vall d'Hebron University Hospital, Western General Hospital, Università Cattolica del Sacro Cuore, Ipsen, Ipsen, Beaujon Hospital, Paris Diderot University, London, UK

Search for other papers by Lucy Wall in
Google Scholar
PubMed
Close
,
Guido Rindi Royal Free Hospital, Charité University Medicine Berlin, University of Warmia and Mazury, University of Texas MD Anderson Cancer Center, University Hospital, Department of Oncology of the First Faculty of Medicine and General Teaching Hospital, Robert‐Debré Hospital, Markey Cancer Center, Vall d'Hebron University Hospital, Western General Hospital, Università Cattolica del Sacro Cuore, Ipsen, Ipsen, Beaujon Hospital, Paris Diderot University, London, UK

Search for other papers by Guido Rindi in
Google Scholar
PubMed
Close
,
Alison Langley Royal Free Hospital, Charité University Medicine Berlin, University of Warmia and Mazury, University of Texas MD Anderson Cancer Center, University Hospital, Department of Oncology of the First Faculty of Medicine and General Teaching Hospital, Robert‐Debré Hospital, Markey Cancer Center, Vall d'Hebron University Hospital, Western General Hospital, Università Cattolica del Sacro Cuore, Ipsen, Ipsen, Beaujon Hospital, Paris Diderot University, London, UK

Search for other papers by Alison Langley in
Google Scholar
PubMed
Close
,
Séverine Martinez Royal Free Hospital, Charité University Medicine Berlin, University of Warmia and Mazury, University of Texas MD Anderson Cancer Center, University Hospital, Department of Oncology of the First Faculty of Medicine and General Teaching Hospital, Robert‐Debré Hospital, Markey Cancer Center, Vall d'Hebron University Hospital, Western General Hospital, Università Cattolica del Sacro Cuore, Ipsen, Ipsen, Beaujon Hospital, Paris Diderot University, London, UK

Search for other papers by Séverine Martinez in
Google Scholar
PubMed
Close
,
Edda Gomez-Panzani Royal Free Hospital, Charité University Medicine Berlin, University of Warmia and Mazury, University of Texas MD Anderson Cancer Center, University Hospital, Department of Oncology of the First Faculty of Medicine and General Teaching Hospital, Robert‐Debré Hospital, Markey Cancer Center, Vall d'Hebron University Hospital, Western General Hospital, Università Cattolica del Sacro Cuore, Ipsen, Ipsen, Beaujon Hospital, Paris Diderot University, London, UK

Search for other papers by Edda Gomez-Panzani in
Google Scholar
PubMed
Close
,
Philippe Ruszniewski Royal Free Hospital, Charité University Medicine Berlin, University of Warmia and Mazury, University of Texas MD Anderson Cancer Center, University Hospital, Department of Oncology of the First Faculty of Medicine and General Teaching Hospital, Robert‐Debré Hospital, Markey Cancer Center, Vall d'Hebron University Hospital, Western General Hospital, Università Cattolica del Sacro Cuore, Ipsen, Ipsen, Beaujon Hospital, Paris Diderot University, London, UK
Royal Free Hospital, Charité University Medicine Berlin, University of Warmia and Mazury, University of Texas MD Anderson Cancer Center, University Hospital, Department of Oncology of the First Faculty of Medicine and General Teaching Hospital, Robert‐Debré Hospital, Markey Cancer Center, Vall d'Hebron University Hospital, Western General Hospital, Università Cattolica del Sacro Cuore, Ipsen, Ipsen, Beaujon Hospital, Paris Diderot University, London, UK

Search for other papers by Philippe Ruszniewski in
Google Scholar
PubMed
Close
, and
on behalf of the CLARINET Investigators
Search for other papers by on behalf of the CLARINET Investigators in
Google Scholar
PubMed
Close

Introduction CLARINET was a landmark 96-week study that confirmed anti-tumour effects for the long-acting somatostatin analogue lanreotide Autogel (depot in the USA) 120 mg. Lanreotide prolonged progression-free survival (PFS) over placebo in

Open access
Jonathan R Strosberg Department of Medicine, Division of Cancer Medicine, Istituto di Oncologia, Novartis International AG, Novartis Pharmaceuticals Corporation, Sarah Cannon Research Institute, University of Paris VII and Beaujon Hospital, Digestive Oncology, Uppsala University Hospital, Department of Hepatology and Gastroenterology, Moffitt Cancer Center, Tampa, Florida, USA

Search for other papers by Jonathan R Strosberg in
Google Scholar
PubMed
Close
,
James C Yao Department of Medicine, Division of Cancer Medicine, Istituto di Oncologia, Novartis International AG, Novartis Pharmaceuticals Corporation, Sarah Cannon Research Institute, University of Paris VII and Beaujon Hospital, Digestive Oncology, Uppsala University Hospital, Department of Hepatology and Gastroenterology, Moffitt Cancer Center, Tampa, Florida, USA

Search for other papers by James C Yao in
Google Scholar
PubMed
Close
,
Emilio Bajetta Department of Medicine, Division of Cancer Medicine, Istituto di Oncologia, Novartis International AG, Novartis Pharmaceuticals Corporation, Sarah Cannon Research Institute, University of Paris VII and Beaujon Hospital, Digestive Oncology, Uppsala University Hospital, Department of Hepatology and Gastroenterology, Moffitt Cancer Center, Tampa, Florida, USA

Search for other papers by Emilio Bajetta in
Google Scholar
PubMed
Close
,
Mounir Aout Department of Medicine, Division of Cancer Medicine, Istituto di Oncologia, Novartis International AG, Novartis Pharmaceuticals Corporation, Sarah Cannon Research Institute, University of Paris VII and Beaujon Hospital, Digestive Oncology, Uppsala University Hospital, Department of Hepatology and Gastroenterology, Moffitt Cancer Center, Tampa, Florida, USA

Search for other papers by Mounir Aout in
Google Scholar
PubMed
Close
,
Bert Bakker Department of Medicine, Division of Cancer Medicine, Istituto di Oncologia, Novartis International AG, Novartis Pharmaceuticals Corporation, Sarah Cannon Research Institute, University of Paris VII and Beaujon Hospital, Digestive Oncology, Uppsala University Hospital, Department of Hepatology and Gastroenterology, Moffitt Cancer Center, Tampa, Florida, USA

Search for other papers by Bert Bakker in
Google Scholar
PubMed
Close
,
John D Hainsworth Department of Medicine, Division of Cancer Medicine, Istituto di Oncologia, Novartis International AG, Novartis Pharmaceuticals Corporation, Sarah Cannon Research Institute, University of Paris VII and Beaujon Hospital, Digestive Oncology, Uppsala University Hospital, Department of Hepatology and Gastroenterology, Moffitt Cancer Center, Tampa, Florida, USA

Search for other papers by John D Hainsworth in
Google Scholar
PubMed
Close
,
Philippe B Ruszniewski Department of Medicine, Division of Cancer Medicine, Istituto di Oncologia, Novartis International AG, Novartis Pharmaceuticals Corporation, Sarah Cannon Research Institute, University of Paris VII and Beaujon Hospital, Digestive Oncology, Uppsala University Hospital, Department of Hepatology and Gastroenterology, Moffitt Cancer Center, Tampa, Florida, USA

Search for other papers by Philippe B Ruszniewski in
Google Scholar
PubMed
Close
,
Eric Van Cutsem Department of Medicine, Division of Cancer Medicine, Istituto di Oncologia, Novartis International AG, Novartis Pharmaceuticals Corporation, Sarah Cannon Research Institute, University of Paris VII and Beaujon Hospital, Digestive Oncology, Uppsala University Hospital, Department of Hepatology and Gastroenterology, Moffitt Cancer Center, Tampa, Florida, USA

Search for other papers by Eric Van Cutsem in
Google Scholar
PubMed
Close
,
Kjell Öberg Department of Medicine, Division of Cancer Medicine, Istituto di Oncologia, Novartis International AG, Novartis Pharmaceuticals Corporation, Sarah Cannon Research Institute, University of Paris VII and Beaujon Hospital, Digestive Oncology, Uppsala University Hospital, Department of Hepatology and Gastroenterology, Moffitt Cancer Center, Tampa, Florida, USA

Search for other papers by Kjell Öberg in
Google Scholar
PubMed
Close
, and
Marianne E Pavel Department of Medicine, Division of Cancer Medicine, Istituto di Oncologia, Novartis International AG, Novartis Pharmaceuticals Corporation, Sarah Cannon Research Institute, University of Paris VII and Beaujon Hospital, Digestive Oncology, Uppsala University Hospital, Department of Hepatology and Gastroenterology, Moffitt Cancer Center, Tampa, Florida, USA

Search for other papers by Marianne E Pavel in
Google Scholar
PubMed
Close

), patients with advanced NET treated with lanreotide autogel (120 mg via deep s.c. injection every 28 days) also had improvement in progression-free survival (PFS) when compared with placebo (PFS, not reached (NR) vs 18 months and HR, 0.47; 95% Cl 0

Open access
Kjell Öberg University Hospital, Uppsala, Sweden

Search for other papers by Kjell Öberg in
Google Scholar
PubMed
Close
and
Steven W J Lamberts Erasmus Medical Center, Rotterdam, The Netherlands

Search for other papers by Steven W J Lamberts in
Google Scholar
PubMed
Close

lanreotide Autogel, the first available sustained-release formulation based on self-assembling nanotube technology ( Fig. 1 ) ( Pouget et al . 2010 ). After administration, lanreotide peptide monomers are slowly released from the ends of the nanotubes over a

Free access
Iulia Potorac CHU de Liège-University of Liège, Liège, Belgium

Search for other papers by Iulia Potorac in
Google Scholar
PubMed
Close
,
Patrick Petrossians CHU de Liège-University of Liège, Liège, Belgium

Search for other papers by Patrick Petrossians in
Google Scholar
PubMed
Close
,
Adrian F Daly CHU de Liège-University of Liège, Liège, Belgium

Search for other papers by Adrian F Daly in
Google Scholar
PubMed
Close
,
Orsalia Alexopoulou Université Catholique de Louvain, Brussels, Belgium

Search for other papers by Orsalia Alexopoulou in
Google Scholar
PubMed
Close
,
Sophie Borot CHU Jean Minjoz, Besancon, France

Search for other papers by Sophie Borot in
Google Scholar
PubMed
Close
,
Mona Sahnoun-Fathallah CHU Marseille, Marseille, France

Search for other papers by Mona Sahnoun-Fathallah in
Google Scholar
PubMed
Close
,
Frederic Castinetti CHU Marseille, Marseille, France

Search for other papers by Frederic Castinetti in
Google Scholar
PubMed
Close
,
France Devuyst Université Libre de Bruxelles, Bruxelles, Belgium

Search for other papers by France Devuyst in
Google Scholar
PubMed
Close
,
Marie-Lise Jaffrain-Rea Department of Biotechnological and Applied Clinical Sciences, University of L’Aquila and Neuroendocrinology, Neuromed IRCCS, Pozzilli, Italy

Search for other papers by Marie-Lise Jaffrain-Rea in
Google Scholar
PubMed
Close
,
Claire Briet CHU Angers, Angers, France

Search for other papers by Claire Briet in
Google Scholar
PubMed
Close
,
Florina Luca CHU Strasbourg, Strasbourg, France

Search for other papers by Florina Luca in
Google Scholar
PubMed
Close
,
Marion Lapoirie CHU Lyon, Lyon, France

Search for other papers by Marion Lapoirie in
Google Scholar
PubMed
Close
,
Flavius Zoicas Universitätsklinikum Erlangen, Erlangen, Germany

Search for other papers by Flavius Zoicas in
Google Scholar
PubMed
Close
,
Isabelle Simoneau CHU Bocage, Dijon, France

Search for other papers by Isabelle Simoneau in
Google Scholar
PubMed
Close
,
Alpha M Diallo CHU Reims, Reims, France

Search for other papers by Alpha M Diallo in
Google Scholar
PubMed
Close
,
Ammar Muhammad Erasmus University Medical Center Rotterdam, Rotterdam, Netherlands

Search for other papers by Ammar Muhammad in
Google Scholar
PubMed
Close
,
Fahrettin Kelestimur Faculty of Medicine, Erciyes University, Kayseri, Turkey

Search for other papers by Fahrettin Kelestimur in
Google Scholar
PubMed
Close
,
Elena Nazzari University of Genova, Genova, Italy

Search for other papers by Elena Nazzari in
Google Scholar
PubMed
Close
,
Rogelio Garcia Centeno Hospital Universitario Gregorio Marañon, Madrid, Spain

Search for other papers by Rogelio Garcia Centeno in
Google Scholar
PubMed
Close
,
Susan M Webb Hospital Sant Pau, Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER, Unidad 747), IIB-Sant Pau, ISCIII and Universitat Autònoma de Barcelona (UAB), Barcelona, Spain

Search for other papers by Susan M Webb in
Google Scholar
PubMed
Close
,
Marie-Laure Nunes CHU Bordeaux, Bordeaux, France

Search for other papers by Marie-Laure Nunes in
Google Scholar
PubMed
Close
,
Vaclav Hana Charles University, Prague, Czech Republic

Search for other papers by Vaclav Hana in
Google Scholar
PubMed
Close
,
Véronique Pascal-Vigneron CHU Nancy, Nancy, France

Search for other papers by Véronique Pascal-Vigneron in
Google Scholar
PubMed
Close
,
Irena Ilovayskaya Moscow Regional Research and Clinical Institute, Russia

Search for other papers by Irena Ilovayskaya in
Google Scholar
PubMed
Close
,
Farida Nasybullina Kazan State Medical Academy, Kazan, Russia

Search for other papers by Farida Nasybullina in
Google Scholar
PubMed
Close
,
Samia Achir Centre Pierre et Marie Curie, Algiers, Algeria

Search for other papers by Samia Achir in
Google Scholar
PubMed
Close
,
Diego Ferone University of Genova, Genova, Italy

Search for other papers by Diego Ferone in
Google Scholar
PubMed
Close
,
Sebastian J C M M Neggers Erasmus University Medical Center Rotterdam, Rotterdam, Netherlands

Search for other papers by Sebastian J C M M Neggers in
Google Scholar
PubMed
Close
,
Brigitte Delemer CHU Reims, Reims, France

Search for other papers by Brigitte Delemer in
Google Scholar
PubMed
Close
,
Jean-Michel Petit CHU Bocage, Dijon, France

Search for other papers by Jean-Michel Petit in
Google Scholar
PubMed
Close
,
Christof Schöfl Center of Endocrinology & Metabolism, Bamberg, Germany

Search for other papers by Christof Schöfl in
Google Scholar
PubMed
Close
,
Gerald Raverot CHU Lyon, Lyon, France

Search for other papers by Gerald Raverot in
Google Scholar
PubMed
Close
,
Bernard Goichot CHU Strasbourg, Strasbourg, France

Search for other papers by Bernard Goichot in
Google Scholar
PubMed
Close
,
Patrice Rodien CHU Angers, Angers, France

Search for other papers by Patrice Rodien in
Google Scholar
PubMed
Close
,
Bernard Corvilain Université Libre de Bruxelles, Bruxelles, Belgium

Search for other papers by Bernard Corvilain in
Google Scholar
PubMed
Close
,
Thierry Brue CHU Marseille, Marseille, France

Search for other papers by Thierry Brue in
Google Scholar
PubMed
Close
,
Franck Schillo CHU Jean Minjoz, Besancon, France

Search for other papers by Franck Schillo in
Google Scholar
PubMed
Close
,
Luaba Tshibanda CHU de Liège-University of Liège, Liège, Belgium

Search for other papers by Luaba Tshibanda in
Google Scholar
PubMed
Close
,
Dominique Maiter Université Catholique de Louvain, Brussels, Belgium

Search for other papers by Dominique Maiter in
Google Scholar
PubMed
Close
,
Jean-François Bonneville CHU de Liège-University of Liège, Liège, Belgium

Search for other papers by Jean-François Bonneville in
Google Scholar
PubMed
Close
, and
Albert Beckers CHU de Liège-University of Liège, Liège, Belgium

Search for other papers by Albert Beckers in
Google Scholar
PubMed
Close

received lanreotide Autogel (among these, one was switched to octreotide LAR), 69 patients received octreotide LAR (among them, two were switched to lanreotide Autogel) and three received pasireotide. For three patients, the SSA dose used was unknown. The

Free access
Dimitrios Papantoniou Department of Medical Sciences, Endocrine Oncology, Uppsala University, Uppsala, Sweden
Department of Oncology, Ryhov County Hospital, Jönköping, Sweden

Search for other papers by Dimitrios Papantoniou in
Google Scholar
PubMed
Close
,
Malin Grönberg Department of Medical Sciences, Endocrine Oncology, Uppsala University, Uppsala, Sweden

Search for other papers by Malin Grönberg in
Google Scholar
PubMed
Close
,
Espen Thiis-Evensen Oslo University Hospital, Rikshospitalet, Deptartment of Organ Transplant, Oslo, Norway

Search for other papers by Espen Thiis-Evensen in
Google Scholar
PubMed
Close
,
Halfdan Sorbye Haukeland Hospital, Deptartment of Oncology, Bergen, Norway
University of Bergen, Deptartment of Clinical Medicine, Bergen, Norway

Search for other papers by Halfdan Sorbye in
Google Scholar
PubMed
Close
,
Kalle Landerholm Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden
Department of Surgery, Ryhov County Hospital, Jönköping, Sweden

Search for other papers by Kalle Landerholm in
Google Scholar
PubMed
Close
,
Staffan Welin Department of Medical Sciences, Endocrine Oncology, Uppsala University, Uppsala, Sweden

Search for other papers by Staffan Welin in
Google Scholar
PubMed
Close
, and
Eva Tiensuu Janson Department of Medical Sciences, Endocrine Oncology, Uppsala University, Uppsala, Sweden

Search for other papers by Eva Tiensuu Janson in
Google Scholar
PubMed
Close

2014 , Lamberti et al. 2020 , Diamantopoulos et al. 2021 ). A prospective phase 2 trial (CLARINET FORTE) with above-label dose of lanreotide autogel recently reported moderate efficacy, with a median PFS of 8.3 months in the Si-NET subgroup. Only

Open access
Johannes Hofland ENETS Center of Excellence, Section of Endocrinology, Department of Internal Medicine, Erasmus MC, Rotterdam, The Netherlands

Search for other papers by Johannes Hofland in
Google Scholar
PubMed
Close
,
Aura D Herrera-Martínez ENETS Center of Excellence, Section of Endocrinology, Department of Internal Medicine, Erasmus MC, Rotterdam, The Netherlands
Maimonides Institute for Biomedical Research of Cordoba (IMIBIC), Córdoba, Spain
Endocrinology and Nutrition Service, Reina Sofia University Hospital, Córdoba, Spain

Search for other papers by Aura D Herrera-Martínez in
Google Scholar
PubMed
Close
,
Wouter T Zandee ENETS Center of Excellence, Section of Endocrinology, Department of Internal Medicine, Erasmus MC, Rotterdam, The Netherlands

Search for other papers by Wouter T Zandee in
Google Scholar
PubMed
Close
, and
Wouter W de Herder ENETS Center of Excellence, Section of Endocrinology, Department of Internal Medicine, Erasmus MC, Rotterdam, The Netherlands

Search for other papers by Wouter W de Herder in
Google Scholar
PubMed
Close

-blind placebo-controlled trials studying the antiproliferative effects of octreotide LAR and lanreotide autogel led to the world-wide registration of these drugs as antiproliferative agents in NET patients. However, the PROMID study ( Rinke et al. 2009

Free access
Louis de Mestier Université de Paris, Department of Gastroenterology-Pancreatology, Beaujon University Hospital (APHP), Clichy, France

Search for other papers by Louis de Mestier in
Google Scholar
PubMed
Close
,
Angela Lamarca Division of Cancer Sciences, Department of Medical Oncology, The Christie NHS Foundation, University of Manchester, Manchester, United Kingdom

Search for other papers by Angela Lamarca in
Google Scholar
PubMed
Close
,
Jorge Hernando Department of Medical Oncology, Vall d’Hebron University Hospital and Vall d´Hebron Institute of Oncology (VHIO), Barcelona, Spain

Search for other papers by Jorge Hernando in
Google Scholar
PubMed
Close
,
Wouter Zandee Department of Internal Medicine, Sector Endocrinology, Erasmus University Medical Center and Erasmus MC Cancer Institute, Rotterdam, The Netherlands
Division of Endocrinology, Department of Internal Medicine, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands

Search for other papers by Wouter Zandee in
Google Scholar
PubMed
Close
,
Teresa Alonso-Gordoa Department of Medical Oncology, Ramon y Cajal University Hospital, IRYCIS, Madrid, Spain

Search for other papers by Teresa Alonso-Gordoa in
Google Scholar
PubMed
Close
,
Marine Perrier Department of Hepato-Gastroenterology and Digestive Oncology, Robert-Debré University Hospital, Reims, France

Search for other papers by Marine Perrier in
Google Scholar
PubMed
Close
,
Annemiek ME Walenkamp Department of Medical Oncology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands

Search for other papers by Annemiek ME Walenkamp in
Google Scholar
PubMed
Close
,
Bipasha Chakrabarty Department of Pathology, The Christie, Manchester, United Kingdom

Search for other papers by Bipasha Chakrabarty in
Google Scholar
PubMed
Close
,
Stefania Landolfi Department of Pathology, Vall d’Hebron University Hospital, Barcelona, Spain

Search for other papers by Stefania Landolfi in
Google Scholar
PubMed
Close
,
Marie-Louise F Van Velthuysen Department of Pathology, Erasmus University Medical Center and Erasmus MC Cancer Institute, Rotterdam, The Netherlands

Search for other papers by Marie-Louise F Van Velthuysen in
Google Scholar
PubMed
Close
,
Gursah Kats-Ugurlu Department of Pathology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands

Search for other papers by Gursah Kats-Ugurlu in
Google Scholar
PubMed
Close
,
Alejandra Caminoa Department of Pathology, University Hospital Ramon y Cajal, Madrid, Spain

Search for other papers by Alejandra Caminoa in
Google Scholar
PubMed
Close
,
Maxime Ronot Université de Paris, Department of Radiology, Beaujon University Hospital (APHP), Clichy, France

Search for other papers by Maxime Ronot in
Google Scholar
PubMed
Close
,
Prakash Manoharan Department of Radiology and Nuclear Medicine, The Christie, Manchester, United Kingdom

Search for other papers by Prakash Manoharan in
Google Scholar
PubMed
Close
,
Alejandro Garcia-Alvarez Department of Medical Oncology, Vall d’Hebron University Hospital and Vall d´Hebron Institute of Oncology (VHIO), Barcelona, Spain

Search for other papers by Alejandro Garcia-Alvarez in
Google Scholar
PubMed
Close
,
Tessa Brabander Department of Radiology and Nuclear Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands

Search for other papers by Tessa Brabander in
Google Scholar
PubMed
Close
,
María Isabel García Gómez-Muriel Department of Radiology, University Hospital Ramon y Cajal, Madrid, Spain

Search for other papers by María Isabel García Gómez-Muriel in
Google Scholar
PubMed
Close
,
Guillaume Cadiot Department of Hepato-Gastroenterology and Digestive Oncology, Robert-Debré University Hospital, Reims, France

Search for other papers by Guillaume Cadiot in
Google Scholar
PubMed
Close
,
Anne Couvelard Université de Paris, Department of Pathology, Beaujon/Bichat University Hospital (APHP), Clichy/Paris, France

Search for other papers by Anne Couvelard in
Google Scholar
PubMed
Close
,
Jaume Capdevila Department of Medical Oncology, Vall d’Hebron University Hospital and Vall d´Hebron Institute of Oncology (VHIO), Barcelona, Spain

Search for other papers by Jaume Capdevila in
Google Scholar
PubMed
Close
,
Marianne E Pavel Department of Endocrinology, Erlangen University Hospital, Erlangen, Germany

Search for other papers by Marianne E Pavel in
Google Scholar
PubMed
Close
, and
Jérôme Cros Université de Paris, Department of Pathology, Beaujon/Bichat University Hospital (APHP), Clichy/Paris, France

Search for other papers by Jérôme Cros in
Google Scholar
PubMed
Close

collected, as well as follow-up data. Treatments were regrouped as alkylating-based CT (temozolomide-, dacarbazine- or streptozotocin-based), etoposide-platinum CT, adenocarcinoma-like CT (FOLFOX- or FOLFIRI-based), somatostatin analogs (lanreotide autogel

Restricted access
M C F Mulders Department of Internal Medicine, ENETS Center of Excellence, Section of Endocrinology, Erasmus Medical Center and Erasmus Medical Center Cancer Institute, Rotterdam, The Netherlands

Search for other papers by M C F Mulders in
Google Scholar
PubMed
Close
,
Q G de Lussanet de la Sablonière Department of Radiology and Nuclear Medicine, Erasmus Medical Center, Rotterdam, The Netherlands

Search for other papers by Q G de Lussanet de la Sablonière in
Google Scholar
PubMed
Close
,
M L F van Velthuysen Department of Pathology, Erasmus Medical Center, Rotterdam, The Netherlands

Search for other papers by M L F van Velthuysen in
Google Scholar
PubMed
Close
,
E M Roes Department of Gynecologic Oncology, Erasmus Medical Center Cancer Institute, Rotterdam, The Netherlands

Search for other papers by E M Roes in
Google Scholar
PubMed
Close
,
J Hofland Department of Internal Medicine, ENETS Center of Excellence, Section of Endocrinology, Erasmus Medical Center and Erasmus Medical Center Cancer Institute, Rotterdam, The Netherlands

Search for other papers by J Hofland in
Google Scholar
PubMed
Close
, and
W W de Herder Department of Internal Medicine, ENETS Center of Excellence, Section of Endocrinology, Erasmus Medical Center and Erasmus Medical Center Cancer Institute, Rotterdam, The Netherlands

Search for other papers by W W de Herder in
Google Scholar
PubMed
Close

). Regarding patients on SSA treatment, only those on a stable dose of either octreotide LAR (30 mg/4 weeks) or lanreotide autogel (120 mg/4 weeks) were selected for TGR analysis. Statistics Data are presented as mean ± s.d. for normally distributed

Restricted access
Benjamin Easton White Department of Gastroenterology, Hampshire Hospitals NHS Foundation Trust, Basingstoke, Hampshire, UK

Search for other papers by Benjamin Easton White in
Google Scholar
PubMed
Close
,
Maralyn R Druce Centre for Endocrinology, Barts and the London School of Medicine and Dentistry, London, UK

Search for other papers by Maralyn R Druce in
Google Scholar
PubMed
Close
,
Simona Grozinsky-Glasberg Neuroendocrine Tumor Unit, ENETS Center of Excellence, Department of Endocrinology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel

Search for other papers by Simona Grozinsky-Glasberg in
Google Scholar
PubMed
Close
,
Rajaventhan Srirajaskanthan King’s Health Partners ENETS Centre of Excellence, Kings College hospital, London, UK

Search for other papers by Rajaventhan Srirajaskanthan in
Google Scholar
PubMed
Close
,
Eva Maria Gamper Eva Maria Gamper – Innsbruck Institute of Patient-centered Outcome Research (IIPCOR), Innsbruck, Austria

Search for other papers by Eva Maria Gamper in
Google Scholar
PubMed
Close
,
Debra Gray Department of Psychology, University of Winchester, Hampshire, UK

Search for other papers by Debra Gray in
Google Scholar
PubMed
Close
,
Ruben Mujica-Mota Academic Unit of Health Economics, Institute of Health Sciences, University of Leeds, Leeds, UK

Search for other papers by Ruben Mujica-Mota in
Google Scholar
PubMed
Close
, and
John K Ramage Department of Gastroenterology, Hampshire Hospitals NHS Foundation Trust, Basingstoke, Hampshire, UK
King’s Health Partners ENETS Centre of Excellence, Kings College hospital, London, UK

Search for other papers by John K Ramage in
Google Scholar
PubMed
Close

Molecular Imaging 46 2252 – 2259 . ( https://doi.org/10.1007/s00259-019-04431-3 ) Martín-Richard M Massutí B Pineda E Alonso V Marmol M Castellano D 2013 Antiproliferative effects of lanreotide autogel in patients with progressive, well

Free access